KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Assets: 2018-2024

Historic Return on Assets for Amneal Pharmaceuticals (AMRX) over the last 7 years, with Dec 2024 value amounting to -0.02%.

  • Amneal Pharmaceuticals' Return on Assets rose 6.00% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -0.02% for FY2024, which is 1.00% down from last year.
  • Amneal Pharmaceuticals' Return on Assets amounted to -0.02% in FY2024, which was down 58.03% from -0.01% recorded in FY2023.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Assets ranged from a high of 0.02% in FY2020 and a low of -0.07% during FY2022.
  • For the 3-year period, Amneal Pharmaceuticals' Return on Assets averaged around -0.03%, with its median value being -0.02% (2024).
  • Its Return on Assets has fluctuated over the past 5 years, first grew by 17bps in 2020, then declined by 7bps in 2022.
  • Amneal Pharmaceuticals' Return on Assets (Yearly) stood at 0.02% in 2020, then fell by 1bps to 0.01% in 2021, then dropped by 7bps to -0.07% in 2022, then climbed by 5bps to -0.01% in 2023, then decreased by 1bps to -0.02% in 2024.